Matches in Wikidata for { <http://www.wikidata.org/entity/Q91563093> ?p ?o ?g. }
Showing items 1 to 51 of
51
with 100 items per page.
- Q91563093 description "artículu científicu espublizáu en xunetu de 2019" @default.
- Q91563093 description "im Juli 2019 veröffentlichter wissenschaftlicher Artikel" @default.
- Q91563093 description "scientific article published on 02 July 2019" @default.
- Q91563093 description "wetenschappelijk artikel" @default.
- Q91563093 description "наукова стаття, опублікована 2 липня 2019" @default.
- Q91563093 description "գիտական հոդված հրատարակված 2019 թվականի հուլիսի 2-ին" @default.
- Q91563093 name "Immune Checkpoint Blockade Enhances Shared Neoantigen-Induced T-cell Immunity Directed against Mutated Calreticulin in Myeloproliferative Neoplasms" @default.
- Q91563093 name "Immune Checkpoint Blockade Enhances Shared Neoantigen-Induced T-cell Immunity Directed against Mutated Calreticulin in Myeloproliferative Neoplasms" @default.
- Q91563093 type Item @default.
- Q91563093 label "Immune Checkpoint Blockade Enhances Shared Neoantigen-Induced T-cell Immunity Directed against Mutated Calreticulin in Myeloproliferative Neoplasms" @default.
- Q91563093 label "Immune Checkpoint Blockade Enhances Shared Neoantigen-Induced T-cell Immunity Directed against Mutated Calreticulin in Myeloproliferative Neoplasms" @default.
- Q91563093 prefLabel "Immune Checkpoint Blockade Enhances Shared Neoantigen-Induced T-cell Immunity Directed against Mutated Calreticulin in Myeloproliferative Neoplasms" @default.
- Q91563093 prefLabel "Immune Checkpoint Blockade Enhances Shared Neoantigen-Induced T-cell Immunity Directed against Mutated Calreticulin in Myeloproliferative Neoplasms" @default.
- Q91563093 P1433 Q91563093-FADAC3B2-DA34-41F1-93C4-AAE5B4BB2AB5 @default.
- Q91563093 P1476 Q91563093-971DD880-6F80-4B3E-8F91-075BED938B36 @default.
- Q91563093 P2093 Q91563093-1E48D16C-15BC-4EFC-A783-556481DDDBA3 @default.
- Q91563093 P2093 Q91563093-21EA8400-5828-4B87-8199-BAD8D3C7B45C @default.
- Q91563093 P2093 Q91563093-6A04C55C-1215-4E52-9F44-1324519BA8C8 @default.
- Q91563093 P2093 Q91563093-9EFB267B-13EA-4D3E-BA6D-5C48AB175ADD @default.
- Q91563093 P2093 Q91563093-B49360B9-209A-4483-8412-EE8FF6B2291F @default.
- Q91563093 P2860 Q91563093-51E59888-2DC3-44DD-B5A7-BA4713AEF746 @default.
- Q91563093 P304 Q91563093-E6DFEE79-BF0A-4F7E-8217-685F28B008C1 @default.
- Q91563093 P31 Q91563093-7707BC37-9682-4219-A514-51726D70BAB3 @default.
- Q91563093 P356 Q91563093-61E20CF0-B1D4-4989-9184-7CE1BE5661A9 @default.
- Q91563093 P433 Q91563093-B20DB1D3-C28A-43F3-8CD1-3783AFDEA810 @default.
- Q91563093 P478 Q91563093-838B7F0A-D1FF-46C7-96FE-AC707626A169 @default.
- Q91563093 P50 Q91563093-543B87DA-2B95-4D19-BFB2-F47F45984557 @default.
- Q91563093 P50 Q91563093-F0A5EDD6-7272-4072-9EDA-C3547BEA5064 @default.
- Q91563093 P577 Q91563093-D033AD2B-DE55-42E9-B41A-73C3B0C12FF3 @default.
- Q91563093 P698 Q91563093-5BCE75C6-2605-4C5B-BA89-38B3DB4DF5BC @default.
- Q91563093 P932 Q91563093-66B12D7C-9DC8-4FF9-B45A-078262A8B7DB @default.
- Q91563093 P356 2159-8290.CD-18-1356 @default.
- Q91563093 P698 31266769 @default.
- Q91563093 P1433 Q15724440 @default.
- Q91563093 P1476 "Immune Checkpoint Blockade Enhances Shared Neoantigen-Induced T-cell Immunity Directed against Mutated Calreticulin in Myeloproliferative Neoplasms" @default.
- Q91563093 P2093 "Camelia Iancu-Rubin" @default.
- Q91563093 P2093 "Cansu Cimen Bozkus" @default.
- Q91563093 P2093 "John Mascarenhas" @default.
- Q91563093 P2093 "Ronald Hoffman" @default.
- Q91563093 P2093 "Vladimir Roudko" @default.
- Q91563093 P2860 Q29615679 @default.
- Q91563093 P304 "1192-1207" @default.
- Q91563093 P31 Q13442814 @default.
- Q91563093 P356 "10.1158/2159-8290.CD-18-1356" @default.
- Q91563093 P433 "9" @default.
- Q91563093 P478 "9" @default.
- Q91563093 P50 Q101410016 @default.
- Q91563093 P50 Q85660592 @default.
- Q91563093 P577 "2019-07-02T00:00:00Z" @default.
- Q91563093 P698 "31266769" @default.
- Q91563093 P932 "6726533" @default.